Noun
gantenerumab (uncountable)
(pharmacology) A monoclonal antibody used as an immunomodulator in the treatment of Alzheimer's disease.
Gantenerumab is also being studied as part of the DIAN-TU trial, a worldwide clinical study evaluating multiple compounds in individuals at risk for or with a type of early-onset AD caused by a genetic mutation. Source: Internet